
|Articles|October 1, 2003
CELL-BASED WOUND TX TO BE DEVELOPED
An affiliate company of DFB Pharmaceuticals Inc, Healthpoint, Ltd., has signed an exclusive agreement with IsoTis, S.A. to develop and license its patented, biologic, wound-healing technology called Allox.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Auricular Acupuncture for Facial Rejuvenation: Results from a Large Real-World Clinical Series
2
Sun Pharma’s Cosibelimab-ipdl (UNLOXCYT) Enters US Market for Advanced CSCC
3
Lebrikizumab Enters Late-Stage Testing for Nummular Eczema
4
Graham Heap, MBBS, PhD, Discusses Positive Phase 3 Results for Zasocitinib
5


















